Injective's native token INJ is trading near a critical level, hovering just below the $3.88 resistance mark. On-chain data shows large holders are overwhelmingly betting on a breakout, with 65.1% of whale positions currently long. The funding rate has also flipped positive, meaning traders are paying a premium to hold long positions — a sign that bullish conviction is building.
Why the $3.88 level matters
For weeks, $3.88 has acted as a ceiling for INJ. Every attempt to push through has been met with selling pressure, turning that price into a make-or-break zone. A clean break above it would open the door to the next target of $4.20, according to market watchers. But if the resistance holds, the same data points to a sharp reversal. The funding-rate imbalance suggests a crowded long trade — and crowded trades often end badly when the price doesn't cooperate.
Whale positioning and funding rates
The 65.1% long split among whale wallets is unusually lopsided. It means the big players are heavily concentrated on one side of the trade. Funding rates, which measure the cost of holding leveraged positions, are currently favoring bulls. That's a typical setup during a rally, but it also raises the risk of a long squeeze. If $3.88 rejects, forced liquidations could accelerate a drop, and the same conditions that look bullish now could flip viciously bearish within minutes.
Two paths forward
Right now, the market is pricing in a binary outcome. The predicted path on a breakout is a swift move to $4.20, with traders expecting momentum to carry through quickly. On the flip side, a rejection at $3.88 is expected to trigger a price crash — though exactly how deep that crash goes depends on where stop-losses and liquidations cluster. No one is forecasting a slow bleed. Either INJ clears the hurdle and runs, or it fails hard and fast.
For now, the token sits at the threshold. The next few trading sessions will determine which scenario plays out.
